1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Heart Failure Drugs Annual Sales 2017-2028 2.1.2 World Current & Future Analysis for Heart Failure Drugs by Geographic Region, 2017, 2022 & 2028 2.1.3 World Current & Future Analysis for Heart Failure Drugs by Country/Region, 2017, 2022 & 2028 2.2 Heart Failure Drugs Segment by Type 2.2.1 ACEI 2.2.2 Angiotensin II Receptor Blockers 2.2.3 ARNIs 2.2.4 Beta Blockers 2.2.5 Aldosterone Antagonists 2.2.6 Diuretics 2.3 Heart Failure Drugs Sales by Type 2.3.1 Global Heart Failure Drugs Sales Market Share by Type (2017-2022) 2.3.2 Global Heart Failure Drugs Revenue and Market Share by Type (2017-2022) 2.3.3 Global Heart Failure Drugs Sale Price by Type (2017-2022) 2.4 Heart Failure Drugs Segment by Application 2.4.1 Reduced Ejection Fraction 2.4.2 Preserved Ejection Fraction 2.5 Heart Failure Drugs Sales by Application 2.5.1 Global Heart Failure Drugs Sale Market Share by Application (2017-2022) 2.5.2 Global Heart Failure Drugs Revenue and Market Share by Application (2017-2022) 2.5.3 Global Heart Failure Drugs Sale Price by Application (2017-2022) 3 Global Heart Failure Drugs by Company 3.1 Global Heart Failure Drugs Breakdown Data by Company 3.1.1 Global Heart Failure Drugs Annual Sales by Company (2020-2022) 3.1.2 Global Heart Failure Drugs Sales Market Share by Company (2020-2022) 3.2 Global Heart Failure Drugs Annual Revenue by Company (2020-2022) 3.2.1 Global Heart Failure Drugs Revenue by Company (2020-2022) 3.2.2 Global Heart Failure Drugs Revenue Market Share by Company (2020-2022) 3.3 Global Heart Failure Drugs Sale Price by Company 3.4 Key Manufacturers Heart Failure Drugs Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Heart Failure Drugs Product Location Distribution 3.4.2 Players Heart Failure Drugs Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Heart Failure Drugs by Geographic Region 4.1 World Historic Heart Failure Drugs Market Size by Geographic Region (2017-2022) 4.1.1 Global Heart Failure Drugs Annual Sales by Geographic Region (2017-2022) 4.1.2 Global Heart Failure Drugs Annual Revenue by Geographic Region 4.2 World Historic Heart Failure Drugs Market Size by Country/Region (2017-2022) 4.2.1 Global Heart Failure Drugs Annual Sales by Country/Region (2017-2022) 4.2.2 Global Heart Failure Drugs Annual Revenue by Country/Region 4.3 Americas Heart Failure Drugs Sales Growth 4.4 APAC Heart Failure Drugs Sales Growth 4.5 Europe Heart Failure Drugs Sales Growth 4.6 Middle East & Africa Heart Failure Drugs Sales Growth 5 Americas 5.1 Americas Heart Failure Drugs Sales by Country 5.1.1 Americas Heart Failure Drugs Sales by Country (2017-2022) 5.1.2 Americas Heart Failure Drugs Revenue by Country (2017-2022) 5.2 Americas Heart Failure Drugs Sales by Type 5.3 Americas Heart Failure Drugs Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Heart Failure Drugs Sales by Region 6.1.1 APAC Heart Failure Drugs Sales by Region (2017-2022) 6.1.2 APAC Heart Failure Drugs Revenue by Region (2017-2022) 6.2 APAC Heart Failure Drugs Sales by Type 6.3 APAC Heart Failure Drugs Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Heart Failure Drugs by Country 7.1.1 Europe Heart Failure Drugs Sales by Country (2017-2022) 7.1.2 Europe Heart Failure Drugs Revenue by Country (2017-2022) 7.2 Europe Heart Failure Drugs Sales by Type 7.3 Europe Heart Failure Drugs Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Heart Failure Drugs by Country 8.1.1 Middle East & Africa Heart Failure Drugs Sales by Country (2017-2022) 8.1.2 Middle East & Africa Heart Failure Drugs Revenue by Country (2017-2022) 8.2 Middle East & Africa Heart Failure Drugs Sales by Type 8.3 Middle East & Africa Heart Failure Drugs Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Heart Failure Drugs 10.3 Manufacturing Process Analysis of Heart Failure Drugs 10.4 Industry Chain Structure of Heart Failure Drugs 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Heart Failure Drugs Distributors 11.3 Heart Failure Drugs Customer 12 World Forecast Review for Heart Failure Drugs by Geographic Region 12.1 Global Heart Failure Drugs Market Size Forecast by Region 12.1.1 Global Heart Failure Drugs Forecast by Region (2023-2028) 12.1.2 Global Heart Failure Drugs Annual Revenue Forecast by Region (2023-2028) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Heart Failure Drugs Forecast by Type 12.7 Global Heart Failure Drugs Forecast by Application 13 Key Players Analysis 13.1 Novartis 13.1.1 Novartis Company Information 13.1.2 Novartis Heart Failure Drugs Product Offered 13.1.3 Novartis Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.1.4 Novartis Main Business Overview 13.1.5 Novartis Latest Developments 13.2 Pfizer 13.2.1 Pfizer Company Information 13.2.2 Pfizer Heart Failure Drugs Product Offered 13.2.3 Pfizer Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.2.4 Pfizer Main Business Overview 13.2.5 Pfizer Latest Developments 13.3 AstraZeneca 13.3.1 AstraZeneca Company Information 13.3.2 AstraZeneca Heart Failure Drugs Product Offered 13.3.3 AstraZeneca Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.3.4 AstraZeneca Main Business Overview 13.3.5 AstraZeneca Latest Developments 13.4 Hikma 13.4.1 Hikma Company Information 13.4.2 Hikma Heart Failure Drugs Product Offered 13.4.3 Hikma Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.4.4 Hikma Main Business Overview 13.4.5 Hikma Latest Developments 13.5 Teva 13.5.1 Teva Company Information 13.5.2 Teva Heart Failure Drugs Product Offered 13.5.3 Teva Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.5.4 Teva Main Business Overview 13.5.5 Teva Latest Developments 13.6 Cipla 13.6.1 Cipla Company Information 13.6.2 Cipla Heart Failure Drugs Product Offered 13.6.3 Cipla Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.6.4 Cipla Main Business Overview 13.6.5 Cipla Latest Developments 13.7 Merck & Co. 13.7.1 Merck & Co. Company Information 13.7.2 Merck & Co. Heart Failure Drugs Product Offered 13.7.3 Merck & Co. Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.7.4 Merck & Co. Main Business Overview 13.7.5 Merck & Co. Latest Developments 13.8 Amgen 13.8.1 Amgen Company Information 13.8.2 Amgen Heart Failure Drugs Product Offered 13.8.3 Amgen Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.8.4 Amgen Main Business Overview 13.8.5 Amgen Latest Developments 13.9 Roche 13.9.1 Roche Company Information 13.9.2 Roche Heart Failure Drugs Product Offered 13.9.3 Roche Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.9.4 Roche Main Business Overview 13.9.5 Roche Latest Developments 13.10 Sun Pharma 13.10.1 Sun Pharma Company Information 13.10.2 Sun Pharma Heart Failure Drugs Product Offered 13.10.3 Sun Pharma Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.10.4 Sun Pharma Main Business Overview 13.10.5 Sun Pharma Latest Developments 13.11 Mylan 13.11.1 Mylan Company Information 13.11.2 Mylan Heart Failure Drugs Product Offered 13.11.3 Mylan Heart Failure Drugs Sales, Revenue, Price and Gross Margin (2020-2022) 13.11.4 Mylan Main Business Overview 13.11.5 Mylan Latest Developments 14 Research Findings and Conclusion

List of Tables Table 1. Heart Failure Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions) Table 2. Heart Failure Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions) Table 3. Major Players of ACEI Table 4. Major Players of Angiotensin II Receptor Blockers Table 5. Major Players of ARNIs Table 6. Major Players of Beta Blockers Table 7. Major Players of Aldosterone Antagonists Table 8. Major Players of Diuretics Table 9. Global Heart Failure Drugs Sales by Type (2017-2022) & (MT) Table 10. Global Heart Failure Drugs Sales Market Share by Type (2017-2022) Table 11. Global Heart Failure Drugs Revenue by Type (2017-2022) & ($ million) Table 12. Global Heart Failure Drugs Revenue Market Share by Type (2017-2022) Table 13. Global Heart Failure Drugs Sale Price by Type (2017-2022) & (USD/MT) Table 14. Global Heart Failure Drugs Sales by Application (2017-2022) & (MT) Table 15. Global Heart Failure Drugs Sales Market Share by Application (2017-2022) Table 16. Global Heart Failure Drugs Revenue by Application (2017-2022) Table 17. Global Heart Failure Drugs Revenue Market Share by Application (2017-2022) Table 18. Global Heart Failure Drugs Sale Price by Application (2017-2022) & (USD/MT) Table 19. Global Heart Failure Drugs Sales by Company (2020-2022) & (MT) Table 20. Global Heart Failure Drugs Sales Market Share by Company (2020-2022) Table 21. Global Heart Failure Drugs Revenue by Company (2020-2022) ($ Millions) Table 22. Global Heart Failure Drugs Revenue Market Share by Company (2020-2022) Table 23. Global Heart Failure Drugs Sale Price by Company (2020-2022) & (USD/MT) Table 24. Key Manufacturers Heart Failure Drugs Producing Area Distribution and Sales Area Table 25. Players Heart Failure Drugs Products Offered Table 26. Heart Failure Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022) Table 27. New Products and Potential Entrants Table 28. Mergers & Acquisitions, Expansion Table 29. Global Heart Failure Drugs Sales by Geographic Region (2017-2022) & (MT) Table 30. Global Heart Failure Drugs Sales Market Share Geographic Region (2017-2022) Table 31. Global Heart Failure Drugs Revenue by Geographic Region (2017-2022) & ($ millions) Table 32. Global Heart Failure Drugs Revenue Market Share by Geographic Region (2017-2022) Table 33. Global Heart Failure Drugs Sales by Country/Region (2017-2022) & (MT) Table 34. Global Heart Failure Drugs Sales Market Share by Country/Region (2017-2022) Table 35. Global Heart Failure Drugs Revenue by Country/Region (2017-2022) & ($ millions) Table 36. Global Heart Failure Drugs Revenue Market Share by Country/Region (2017-2022) Table 37. Americas Heart Failure Drugs Sales by Country (2017-2022) & (MT) Table 38. Americas Heart Failure Drugs Sales Market Share by Country (2017-2022) Table 39. Americas Heart Failure Drugs Revenue by Country (2017-2022) & ($ Millions) Table 40. Americas Heart Failure Drugs Revenue Market Share by Country (2017-2022) Table 41. Americas Heart Failure Drugs Sales by Type (2017-2022) & (MT) Table 42. Americas Heart Failure Drugs Sales Market Share by Type (2017-2022) Table 43. Americas Heart Failure Drugs Sales by Application (2017-2022) & (MT) Table 44. Americas Heart Failure Drugs Sales Market Share by Application (2017-2022) Table 45. APAC Heart Failure Drugs Sales by Region (2017-2022) & (MT) Table 46. APAC Heart Failure Drugs Sales Market Share by Region (2017-2022) Table 47. APAC Heart Failure Drugs Revenue by Region (2017-2022) & ($ Millions) Table 48. APAC Heart Failure Drugs Revenue Market Share by Region (2017-2022) Table 49. APAC Heart Failure Drugs Sales by Type (2017-2022) & (MT) Table 50. APAC Heart Failure Drugs Sales Market Share by Type (2017-2022) Table 51. APAC Heart Failure Drugs Sales by Application (2017-2022) & (MT) Table 52. APAC Heart Failure Drugs Sales Market Share by Application (2017-2022) Table 53. Europe Heart Failure Drugs Sales by Country (2017-2022) & (MT) Table 54. Europe Heart Failure Drugs Sales Market Share by Country (2017-2022) Table 55. Europe Heart Failure Drugs Revenue by Country (2017-2022) & ($ Millions) Table 56. Europe Heart Failure Drugs Revenue Market Share by Country (2017-2022) Table 57. Europe Heart Failure Drugs Sales by Type (2017-2022) & (MT) Table 58. Europe Heart Failure Drugs Sales Market Share by Type (2017-2022) Table 59. Europe Heart Failure Drugs Sales by Application (2017-2022) & (MT) Table 60. Europe Heart Failure Drugs Sales Market Share by Application (2017-2022) Table 61. Middle East & Africa Heart Failure Drugs Sales by Country (2017-2022) & (MT) Table 62. Middle East & Africa Heart Failure Drugs Sales Market Share by Country (2017-2022) Table 63. Middle East & Africa Heart Failure Drugs Revenue by Country (2017-2022) & ($ Millions) Table 64. Middle East & Africa Heart Failure Drugs Revenue Market Share by Country (2017-2022) Table 65. Middle East & Africa Heart Failure Drugs Sales by Type (2017-2022) & (MT) Table 66. Middle East & Africa Heart Failure Drugs Sales Market Share by Type (2017-2022) Table 67. Middle East & Africa Heart Failure Drugs Sales by Application (2017-2022) & (MT) Table 68. Middle East & Africa Heart Failure Drugs Sales Market Share by Application (2017-2022) Table 69. Key Market Drivers & Growth Opportunities of Heart Failure Drugs Table 70. Key Market Challenges & Risks of Heart Failure Drugs Table 71. Key Industry Trends of Heart Failure Drugs Table 72. Heart Failure Drugs Raw Material Table 73. Key Suppliers of Raw Materials Table 74. Heart Failure Drugs Distributors List Table 75. Heart Failure Drugs Customer List Table 76. Global Heart Failure Drugs Sales Forecast by Region (2023-2028) & (MT) Table 77. Global Heart Failure Drugs Sales Market Forecast by Region Table 78. Global Heart Failure Drugs Revenue Forecast by Region (2023-2028) & ($ millions) Table 79. Global Heart Failure Drugs Revenue Market Share Forecast by Region (2023-2028) Table 80. Americas Heart Failure Drugs Sales Forecast by Country (2023-2028) & (MT) Table 81. Americas Heart Failure Drugs Revenue Forecast by Country (2023-2028) & ($ millions) Table 82. APAC Heart Failure Drugs Sales Forecast by Region (2023-2028) & (MT) Table 83. APAC Heart Failure Drugs Revenue Forecast by Region (2023-2028) & ($ millions) Table 84. Europe Heart Failure Drugs Sales Forecast by Country (2023-2028) & (MT) Table 85. Europe Heart Failure Drugs Revenue Forecast by Country (2023-2028) & ($ millions) Table 86. Middle East & Africa Heart Failure Drugs Sales Forecast by Country (2023-2028) & (MT) Table 87. Middle East & Africa Heart Failure Drugs Revenue Forecast by Country (2023-2028) & ($ millions) Table 88. Global Heart Failure Drugs Sales Forecast by Type (2023-2028) & (MT) Table 89. Global Heart Failure Drugs Sales Market Share Forecast by Type (2023-2028) Table 90. Global Heart Failure Drugs Revenue Forecast by Type (2023-2028) & ($ Millions) Table 91. Global Heart Failure Drugs Revenue Market Share Forecast by Type (2023-2028) Table 92. Global Heart Failure Drugs Sales Forecast by Application (2023-2028) & (MT) Table 93. Global Heart Failure Drugs Sales Market Share Forecast by Application (2023-2028) Table 94. Global Heart Failure Drugs Revenue Forecast by Application (2023-2028) & ($ Millions) Table 95. Global Heart Failure Drugs Revenue Market Share Forecast by Application (2023-2028) Table 96. Novartis Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 97. Novartis Heart Failure Drugs Product Offered Table 98. Novartis Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 99. Novartis Main Business Table 100. Novartis Latest Developments Table 101. Pfizer Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 102. Pfizer Heart Failure Drugs Product Offered Table 103. Pfizer Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 104. Pfizer Main Business Table 105. Pfizer Latest Developments Table 106. AstraZeneca Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 107. AstraZeneca Heart Failure Drugs Product Offered Table 108. AstraZeneca Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 109. AstraZeneca Main Business Table 110. AstraZeneca Latest Developments Table 111. Hikma Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 112. Hikma Heart Failure Drugs Product Offered Table 113. Hikma Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 114. Hikma Main Business Table 115. Hikma Latest Developments Table 116. Teva Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 117. Teva Heart Failure Drugs Product Offered Table 118. Teva Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 119. Teva Main Business Table 120. Teva Latest Developments Table 121. Cipla Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 122. Cipla Heart Failure Drugs Product Offered Table 123. Cipla Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 124. Cipla Main Business Table 125. Cipla Latest Developments Table 126. Merck & Co. Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 127. Merck & Co. Heart Failure Drugs Product Offered Table 128. Merck & Co. Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 129. Merck & Co. Main Business Table 130. Merck & Co. Latest Developments Table 131. Amgen Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 132. Amgen Heart Failure Drugs Product Offered Table 133. Amgen Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 134. Amgen Main Business Table 135. Amgen Latest Developments Table 136. Roche Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 137. Roche Heart Failure Drugs Product Offered Table 138. Roche Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 139. Roche Main Business Table 140. Roche Latest Developments Table 141. Sun Pharma Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 142. Sun Pharma Heart Failure Drugs Product Offered Table 143. Sun Pharma Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 144. Sun Pharma Main Business Table 145. Sun Pharma Latest Developments Table 146. Mylan Basic Information, Heart Failure Drugs Manufacturing Base, Sales Area and Its Competitors Table 147. Mylan Heart Failure Drugs Product Offered Table 148. Mylan Heart Failure Drugs Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022) Table 149. Mylan Main Business Table 150. Mylan Latest Developments List of Figures Figure 1. Picture of Heart Failure Drugs Figure 2. Heart Failure Drugs Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Heart Failure Drugs Sales Growth Rate 2017-2028 (MT) Figure 7. Global Heart Failure Drugs Revenue Growth Rate 2017-2028 ($ Millions) Figure 8. Heart Failure Drugs Sales by Region (2021 & 2028) & ($ millions) Figure 9. Product Picture of ACEI Figure 10. Product Picture of Angiotensin II Receptor Blockers Figure 11. Product Picture of ARNIs Figure 12. Product Picture of Beta Blockers Figure 13. Product Picture of Aldosterone Antagonists Figure 14. Product Picture of Diuretics Figure 15. Global Heart Failure Drugs Sales Market Share by Type in 2021 Figure 16. Global Heart Failure Drugs Revenue Market Share by Type (2017-2022) Figure 17. Heart Failure Drugs Consumed in Reduced Ejection Fraction Figure 18. Global Heart Failure Drugs Market: Reduced Ejection Fraction (2017-2022) & (MT) Figure 19. Heart Failure Drugs Consumed in Preserved Ejection Fraction Figure 20. Global Heart Failure Drugs Market: Preserved Ejection Fraction (2017-2022) & (MT) Figure 21. Global Heart Failure Drugs Sales Market Share by Application (2017-2022) Figure 22. Global Heart Failure Drugs Revenue Market Share by Application in 2021 Figure 23. Heart Failure Drugs Revenue Market by Company in 2021 ($ Million) Figure 24. Global Heart Failure Drugs Revenue Market Share by Company in 2021 Figure 25. Global Heart Failure Drugs Sales Market Share by Geographic Region (2017-2022) Figure 26. Global Heart Failure Drugs Revenue Market Share by Geographic Region in 2021 Figure 27. Global Heart Failure Drugs Sales Market Share by Region (2017-2022) Figure 28. Global Heart Failure Drugs Revenue Market Share by Country/Region in 2021 Figure 29. Americas Heart Failure Drugs Sales 2017-2022 (MT) Figure 30. Americas Heart Failure Drugs Revenue 2017-2022 ($ Millions) Figure 31. APAC Heart Failure Drugs Sales 2017-2022 (MT) Figure 32. APAC Heart Failure Drugs Revenue 2017-2022 ($ Millions) Figure 33. Europe Heart Failure Drugs Sales 2017-2022 (MT) Figure 34. Europe Heart Failure Drugs Revenue 2017-2022 ($ Millions) Figure 35. Middle East & Africa Heart Failure Drugs Sales 2017-2022 (MT) Figure 36. Middle East & Africa Heart Failure Drugs Revenue 2017-2022 ($ Millions) Figure 37. Americas Heart Failure Drugs Sales Market Share by Country in 2021 Figure 38. Americas Heart Failure Drugs Revenue Market Share by Country in 2021 Figure 39. United States Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 40. Canada Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 41. Mexico Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 42. Brazil Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 43. APAC Heart Failure Drugs Sales Market Share by Region in 2021 Figure 44. APAC Heart Failure Drugs Revenue Market Share by Regions in 2021 Figure 45. China Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 46. Japan Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 47. South Korea Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 48. Southeast Asia Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 49. India Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 50. Australia Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 51. Europe Heart Failure Drugs Sales Market Share by Country in 2021 Figure 52. Europe Heart Failure Drugs Revenue Market Share by Country in 2021 Figure 53. Germany Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 54. France Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 55. UK Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 56. Italy Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 57. Russia Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 58. Middle East & Africa Heart Failure Drugs Sales Market Share by Country in 2021 Figure 59. Middle East & Africa Heart Failure Drugs Revenue Market Share by Country in 2021 Figure 60. Egypt Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 61. South Africa Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 62. Israel Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 63. Turkey Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 64. GCC Country Heart Failure Drugs Revenue Growth 2017-2022 ($ Millions) Figure 65. Manufacturing Cost Structure Analysis of Heart Failure Drugs in 2021 Figure 66. Manufacturing Process Analysis of Heart Failure Drugs Figure 67. Industry Chain Structure of Heart Failure Drugs Figure 68. Channels of Distribution Figure 69. Distributors Profiles